Daniel J. Wallace
Impact in
- Rheumatology top 0.01%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Immunology top 0.1%
- T-cell and B-cell Immunology
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction
Papers in
- Rheumatology 188
- Systemic Lupus Erythematosus Research 172
- Rheumatoid Arthritis Research and Therapies 16
- Immunology 56
- T-cell and B-cell Immunology 17
- Co-authors
- Michael H. Weisman (60 shared papers)Joan T. Merrill (17 shared papers)Michelle Petri (32 shared papers)Richard Furie (18 shared papers)Ellen M. Ginzler (11 shared papers)James R. Klinenberg (28 shared papers)Mariana Linker‐Israeli (10 shared papers)Kenneth Kalunian (23 shared papers)
- Journals
- Lupus (25 papers)Annals of the Rheumatic Diseases (20 papers)Seminars in Arthritis and Rheumatism (13 papers)Arthritis & Rheumatology (12 papers)Lupus Science & Medicine (9 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Daniel J. Wallace
282 papers receiving 15.9k citations
Daniel J. Wallace's Hit Papers
Peers
Comparison fields: 5 of 165
- Rheumatology 10.7k
- Immunology 6.3k
- Radiology, Nuclear Medicine and Imaging 3.4k
- Nephrology 966
- Hepatology 585
Countries citing papers authored by Daniel J. Wallace
This map shows the geographic impact of Daniel J. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Wallace more than expected).
Fields of papers citing papers by Daniel J. Wallace
This network shows the impact of papers produced by Daniel J. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Wallace. The network helps show where Daniel J. Wallace may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel J. Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 294 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Hit paper breakdown → | 2011 | 1166 |
| 2 | Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial Hit paper breakdown → | 2009 | 984 |
| 3 | Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis Hit paper breakdown → | 2005 | 770 |
| 4 | Dubois' Lupus Erythematosus Hit paper breakdown → | 1988 | 561 |
| 5 | Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) Hit paper breakdown → | 2005 | 500 |
| 6 | 2003 | 461 | |
| 7 | 1991 | 444 | |
| 8 | A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus Hit paper breakdown → | 2009 | 412 |
| 9 | Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial Hit paper breakdown → | 2018 | 364 |
| 10 | 2009 | 345 | |
| 11 | 2006 | 327 | |
| 12 | 2010 | 278 | |
| 13 | 2013 | 254 | |
| 14 | 2001 | 253 | |
| 15 | 2007 | 248 | |
| 16 | 1981 | 210 | |
| 17 | 1997 | 201 | |
| 18 | 2006 | 201 | |
| 19 | 2013 | 200 | |
| 20 | 2015 | 182 |
About Daniel J. Wallace
Daniel J. Wallace is a scholar working on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Physiology, having authored 294 papers that have together received 16.5k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (172 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), T-cell and B-cell Immunology (17 papers), Rheumatoid Arthritis Research and Therapies (16 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (14 papers), Autoimmune and Inflammatory Disorders Research (10 papers), Renal Diseases and Glomerulopathies (10 papers) and Systemic Sclerosis and Related Diseases (9 papers). The work is most often cited by research in Rheumatology (10.7k citations), Immunology (6.3k citations), Radiology, Nuclear Medicine and Imaging (3.4k citations), Nephrology (966 citations) and Hepatology (585 citations). Daniel J. Wallace has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Michael H. Weisman, Joan T. Merrill, Michelle Petri, Richard Furie, Ellen M. Ginzler, James R. Klinenberg, Mariana Linker‐Israeli, Kenneth Kalunian, David Isenberg and William Stohl. Their work appears in journals such as Lupus, Annals of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism, Arthritis & Rheumatology and Lupus Science & Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.